Literature DB >> 25663521

Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.

Paulomi Paul1, Abhishek Chowdhury, Anupam Das Talukdar, Manabendra Dutta Choudhury.   

Abstract

Malaria is an infectious disease caused by parasites of the genus Plasmodium. It leads to approximately 1 million deaths per annum worldwide, with an increase number of 6.27 million deaths in 2012 alone. Validation of new antimalarial targets is very important in the context of the rise in resistance to current drugs. One such putative target is the enzyme N-myristoyltransferase (NMT), which catalyzes the attachment of the fatty acid myristate to protein substrates (N-myristoylation) for activation. Reports suggests that NMT is an essential and chemically docile target in malaria parasites both in vitro and in vivo, and the selective inhibition of N-myristoylation leads to irreversible failure to form an inner membrane complex—an essential subcellular organelle in the parasite life cycle. In this work, we modeled the three-dimensional structure of Plasmodium falciparum NMT (PfNMT) using Modeler 9.0 taking Plasmodium vivax NMT (PvNMT) as the template. The novelty of the work lies in the selection of template as the similarity of PfNMT with PvNMT was 80.47%, whereas earlier similar work showed template similarity with Candida albicans NMT (CaNMT) and Saccharomyces cerevisiae NMT (ScNMT) to be less than 50%. The generated structure was then validated using various programs such as PROCHECK, RAMPAGE server, CHIMERA and the stability of the model was checked by Gromacs 5.0.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25663521     DOI: 10.1007/s00894-015-2586-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  17 in total

1.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

2.  HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment.

Authors:  Michael Remmert; Andreas Biegert; Andreas Hauser; Johannes Söding
Journal:  Nat Methods       Date:  2011-12-25       Impact factor: 28.547

3.  Assessment of template based protein structure predictions in CASP9.

Authors:  Valerio Mariani; Florian Kiefer; Tobias Schmidt; Juergen Haas; Torsten Schwede
Journal:  Proteins       Date:  2011-10-15

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.

Authors:  B Devadas; S K Freeman; M E Zupec; H F Lu; S R Nagarajan; N S Kishore; J K Lodge; D W Kuneman; C A McWherter; D V Vinjamoori; D P Getman; J I Gordon; J A Sikorski
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

Review 6.  Post-translational chemical modification(s) of proteins.

Authors:  K K Han; A Martinage
Journal:  Int J Biochem       Date:  1992

7.  Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.

Authors:  Chunquan Sheng; Haitao Ji; Zhenyuan Miao; Xiaoyin Che; Jianzhong Yao; Wenya Wang; Guoqiang Dong; Wei Guo; Jiaguo Lü; Wannian Zhang
Journal:  J Comput Aided Mol Des       Date:  2009-04-16       Impact factor: 3.686

Review 8.  Protein N-myristoylation: simple questions, unexpected answers.

Authors:  J I Gordon
Journal:  Clin Res       Date:  1990-10

9.  SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Authors:  N Guex; M C Peitsch
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

Review 10.  Myristoylation.

Authors:  J A Boutin
Journal:  Cell Signal       Date:  1997-01       Impact factor: 4.315

View more
  3 in total

1.  Virtual screening to identify Leishmania braziliensis N-myristoyltransferase inhibitors: pharmacophore models, docking, and molecular dynamics.

Authors:  Juliana Cecília de Carvalho Gallo; Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; Isis Bugia Santana; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-08-29       Impact factor: 1.810

2.  Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer.

Authors:  Zhong Ni; Tian-Cheng Zhang
Journal:  J Mol Model       Date:  2015-06-18       Impact factor: 1.810

3.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.